Literature DB >> 26998017

Effects of lactadherin on plasma D-lactic acid and small intestinal MUC2 and claudin-1 expression levels in rats with rotavirus-induced diarrhea.

Rui Xu1, Yi-Hui Lei2, Jun Shi1, Yi-Jun Zhou1, Ying-Wei Chen3, Zhen-Juan He4.   

Abstract

The aim of the present study was to investigate the effects of lactadherin on plasma D-lactic acid and small intestinal mucin (MUC) 2 and claudin-1 expression levels in rats with diarrhea induced by rotavirus (RV) infection. A total of 75 seven-day-old healthy Sprague-Dawley rats were randomly divided into the following five groups: Control (C), RV infection (RVI), lactadherin before rotavirus infection (LBRI), lactadherin after rotavirus infection (LARI), and blank (B). On day 4 of artificial feeding, the rats in groups RVI, LBRI and LARI were intragastric administered 1×106 PFU RV; whereas the rats in groups C and B were intragastrically administered an equal volume of maintenance solution from the RV supernatant and normal saline, respectively. In the LBRI and LARI groups, rats received daily intragastric administration of 0.25 mg lactadherin for three days prior to and following infection with RV, respectively. The course of diarrheal symptoms was observed in each group and samples were collected on days 1, 4, and 7 post-infection in order to determine the mucosal morphology, plasma D-lactic acid levels and the expression levels of MUC2 and the intracellular junction protein, claudin-1, in the small intestine. On day 4 post-infection, the rats in group RVI demonstrated severely damaged small intestines and typical diarrheal characteristics, as detected by light microscopy; whereas rats in groups LBRI and LARI demonstrated intact small intestinal villi with partial vacuolation of epithelial cells and changes in the position of their nuclei. Electron microscopy demonstrated that the rats in the RVI group had sparse, shortened, disordered intestinal microvilli and widened intercellular junctions; whereas those in groups LBRI and LARI had long intestinal microvilli sparser compared with groups B and C and slightly widened intercellular junctions. Plasma D-lactic acid levels were increased in groups RVI, LBRI and LARI, as compared with groups B and C, and the greatest levels were detected in the RVI group on days 1, 4 and 7 post-infection. In addition to maintaining intestinal permeability, lactadherin enhanced the expression levels of MUC2 and reduced the expression of claudin-1; therefore, further protecting the intestinal epithelial barrier, which may contribute to the prevention and treatment of diarrhea induced by infection with RV.

Entities:  

Keywords:  barrier; lactadherin; neonatal rats; rotavirus infection; small intestine

Year:  2016        PMID: 26998017      PMCID: PMC4774346          DOI: 10.3892/etm.2016.3015

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  26 in total

Review 1.  Prevention and treatment of enteric viral infections: possible benefits of probiotic bacteria.

Authors:  Florence Colbère-Garapin; Sandra Martin-Latil; Bruno Blondel; Laurence Mousson; Isabelle Pelletier; Arnaud Autret; Alan François; Violeta Niborski; Gianfranco Grompone; Guillaume Catonnet; Ariane van de Moer
Journal:  Microbes Infect       Date:  2007-10-02       Impact factor: 2.700

Review 2.  D-lactic acidosis: pathologic consequence of saprophytism.

Authors:  A Vella; G Farrugia
Journal:  Mayo Clin Proc       Date:  1998-05       Impact factor: 7.616

3.  Cloning, high level expression of human paraoxonase-3 in Sf9 cells and pharmacological characterization of its product.

Authors:  Haiqin Lu; Jie Zhu; Yuhui Zang; Yuguan Ze; Junchuan Qin
Journal:  Biochem Pharmacol       Date:  2005-10-01       Impact factor: 5.858

4.  Increase in the tight junction protein claudin-1 in intestinal inflammation.

Authors:  Lisa S Poritz; Leonard R Harris; Ashley A Kelly; Walter A Koltun
Journal:  Dig Dis Sci       Date:  2011-07-12       Impact factor: 3.199

5.  Homeostasis and function of goblet cells during rotavirus infection in mice.

Authors:  Jos A Boshuizen; Johan H J Reimerink; Anita M Korteland-van Male; Vanessa J J van Ham; Janneke Bouma; Gerrit J Gerwig; Marion P G Koopmans; Hans A Büller; Jan Dekker; Alexandra W C Einerhand
Journal:  Virology       Date:  2005-07-05       Impact factor: 3.616

Review 6.  Rotavirus infection and the current status of rotavirus vaccines.

Authors:  Shou-Chien Chen; Lia-Beng Tan; Li-Min Huang; Kow-Tong Chen
Journal:  J Formos Med Assoc       Date:  2012-03-29       Impact factor: 3.282

7.  Mucin production and composition is altered in dextran sulfate sodium-induced colitis in rats.

Authors:  M Faure; D Moënnoz; F Montigon; C Mettraux; S Mercier; E J Schiffrin; C Obled; D Breuillé; J Boza
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

8.  Changes in small intestinal homeostasis, morphology, and gene expression during rotavirus infection of infant mice.

Authors:  Jos A Boshuizen; Johan H J Reimerink; Anita M Korteland-van Male; Vanessa J J van Ham; Marion P G Koopmans; Hans A Büller; Jan Dekker; Alexandra W C Einerhand
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

9.  Inhibitory effects of human and bovine milk constituents on rotavirus infections.

Authors:  A S Kvistgaard; L T Pallesen; C F Arias; S López; T E Petersen; C W Heegaard; J T Rasmussen
Journal:  J Dairy Sci       Date:  2004-12       Impact factor: 4.034

Review 10.  Global causes of diarrheal disease mortality in children <5 years of age: a systematic review.

Authors:  Claudio F Lanata; Christa L Fischer-Walker; Ana C Olascoaga; Carla X Torres; Martin J Aryee; Robert E Black
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

View more
  3 in total

1.  Protective effect of aplysin on liver tissue and the gut microbiota in alcohol-fed rats.

Authors:  Meilan Xue; Ying Liu; Rui Lyu; Na Ge; Man Liu; Yan Ma; Hui Liang
Journal:  PLoS One       Date:  2017-06-16       Impact factor: 3.240

2.  Impaired intestinal barrier function in a mouse model of hyperuricemia.

Authors:  Yingjie Guo; Hailong Li; Zhen Liu; Changgui Li; Yunqing Chen; Chen Jiang; Yanan Yu; Zibin Tian
Journal:  Mol Med Rep       Date:  2019-08-12       Impact factor: 2.952

3.  Qiweibaizhu Decoction Treats Diarrheal Juvenile Rats by Modulating the Gut Microbiota, Short-Chain Fatty Acids, and the Mucus Barrier.

Authors:  Shaodan Sun; Yang Yang; Xiaojie Lin; Peiwen Chen; Liyan Ye; Liying Zeng; Qina Ye; Xiangna Yang; Jingtu Ceng; Jiayi Shan; Li Xie; Meirong Jiang; Fei Luo; Xiaogang Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-17       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.